These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
443 related items for PubMed ID: 31978804
21. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction. Han A, Lu Y, Zheng Q, Zhang J, Zhao Y, Zhao M, Cui X. Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381 [Abstract] [Full Text] [Related]
26. Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway. Liu A, Gao X, Zhang Q, Cui L. Mol Med Rep; 2013 Aug; 8(2):361-6. PubMed ID: 23732925 [Abstract] [Full Text] [Related]
27. Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4/NF-kB/NLRP3 pathway. Luo M, Yan D, Sun Q, Tao J, Xu L, Sun H, Zhao H. J Cell Biochem; 2020 Apr; 121(4):2994-3004. PubMed ID: 31709615 [Abstract] [Full Text] [Related]
28. Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis. Bian Y, Li X, Pang P, Hu XL, Yu ST, Liu YN, Li X, Wang N, Wang JH, Xiao W, Du WJ, Yang BF. Acta Pharmacol Sin; 2020 Mar; 41(3):319-326. PubMed ID: 31645662 [Abstract] [Full Text] [Related]
32. Role of NLRP3 Inflammasome in Cardiac Inflammation and Remodeling after Myocardial Infarction. Takahashi M. Biol Pharm Bull; 2019 Mar; 42(4):518-523. PubMed ID: 30930410 [Abstract] [Full Text] [Related]
33. Chikusetsu saponin IVa ameliorates high fat diet-induced inflammation in adipose tissue of mice through inhibition of NLRP3 inflammasome activation and NF-κB signaling. Yuan C, Liu C, Wang T, He Y, Zhou Z, Dun Y, Zhao H, Ren D, Wang J, Zhang C, Yuan D. Oncotarget; 2017 May 09; 8(19):31023-31040. PubMed ID: 28415686 [Abstract] [Full Text] [Related]
39. Sweroside alleviates pressure overload-induced heart failure through targeting CaMKⅡδ to inhibit ROS-mediated NF-κB/NLRP3 in cardiomyocytes. Wang D, Yu X, Gao K, Li F, Li X, Pu H, Zhang P, Guo S, Wang W. Redox Biol; 2024 Aug 09; 74():103223. PubMed ID: 38851078 [Abstract] [Full Text] [Related]